Bain Capital Public Equity Management as of Dec. 31, 2017
Portfolio Holdings for Bain Capital Public Equity Management
Bain Capital Public Equity Management holds 76 positions in its portfolio as reported in the December 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Altaba | 20.1 | $278M | 4.0M | 69.85 | |
Nxp Semiconductors N V (NXPI) | 5.9 | $81M | 693k | 117.09 | |
Citrix Systems | 5.3 | $73M | 824k | 88.00 | |
Godaddy Inc cl a (GDDY) | 4.3 | $60M | 1.2M | 50.28 | |
Gartner (IT) | 4.1 | $56M | 456k | 123.15 | |
Ball Corporation (BALL) | 3.4 | $46M | 1.2M | 37.85 | |
Comcast Corporation (CMCSA) | 2.9 | $40M | 1.0M | 40.05 | |
O'reilly Automotive (ORLY) | 2.9 | $40M | 166k | 240.54 | |
Honeywell International (HON) | 2.6 | $36M | 237k | 153.36 | |
BioMarin Pharmaceutical (BMRN) | 2.5 | $35M | 392k | 89.17 | |
AutoZone (AZO) | 2.4 | $34M | 47k | 711.38 | |
Mulesoft Inc cl a | 2.4 | $33M | 1.4M | 23.26 | |
Iqvia Holdings (IQV) | 2.4 | $33M | 332k | 97.90 | |
Fortive (FTV) | 2.2 | $30M | 413k | 72.35 | |
Ultimate Software | 1.9 | $26M | 120k | 218.23 | |
New York Times Company (NYT) | 1.6 | $22M | 1.2M | 18.50 | |
Raytheon Company | 1.6 | $22M | 117k | 187.85 | |
Northrop Grumman Corporation (NOC) | 1.6 | $22M | 71k | 306.91 | |
Casey's General Stores (CASY) | 1.6 | $22M | 195k | 111.94 | |
Dover Corporation (DOV) | 1.5 | $21M | 206k | 100.99 | |
Halliburton Company (HAL) | 1.4 | $20M | 399k | 48.87 | |
Essent (ESNT) | 1.4 | $19M | 429k | 43.42 | |
Illinois Tool Works (ITW) | 1.3 | $18M | 108k | 166.85 | |
Navient Corporation equity (NAVI) | 1.3 | $18M | 1.3M | 13.32 | |
WisdomTree Investments (WT) | 1.2 | $16M | 1.3M | 12.55 | |
Hilton Worldwide Holdings (HLT) | 1.1 | $16M | 195k | 79.86 | |
E TRADE Financial Corporation | 1.1 | $16M | 312k | 49.57 | |
State Street Corporation (STT) | 1.0 | $14M | 139k | 97.61 | |
Hubbell (HUBB) | 1.0 | $14M | 100k | 135.34 | |
Immune Design | 0.9 | $13M | 3.3M | 3.90 | |
Oshkosh Corporation (OSK) | 0.9 | $13M | 140k | 90.89 | |
Capital One Financial (COF) | 0.9 | $12M | 119k | 99.58 | |
Cloudera | 0.8 | $11M | 687k | 16.52 | |
China Life Insurance Company | 0.8 | $11M | 3.6M | 3.14 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $11M | 70k | 149.86 | |
Liberty Broadband Cl C (LBRDK) | 0.7 | $10M | 120k | 85.16 | |
Vantiv Inc Cl A | 0.7 | $10M | 136k | 73.55 | |
Schlumberger (SLB) | 0.7 | $9.0M | 133k | 67.39 | |
Merus N V (MRUS) | 0.6 | $8.3M | 196k | 42.31 | |
Avexis | 0.6 | $7.8M | 70k | 110.67 | |
Wright Express (WEX) | 0.5 | $7.1M | 50k | 141.23 | |
United Technologies Corporation | 0.5 | $6.6M | 52k | 127.56 | |
Allegheny Technologies Incorporated (ATI) | 0.5 | $6.6M | 273k | 24.14 | |
Watsco, Incorporated (WSO) | 0.5 | $6.4M | 38k | 170.04 | |
FedEx Corporation (FDX) | 0.5 | $6.3M | 25k | 249.52 | |
Seattle Genetics | 0.5 | $6.2M | 116k | 53.50 | |
AstraZeneca (AZN) | 0.4 | $5.8M | 167k | 34.70 | |
Nektar Therapeutics (NKTR) | 0.4 | $4.9M | 83k | 59.72 | |
Idera Pharmaceuticals | 0.3 | $4.8M | 2.3M | 2.11 | |
Proteostasis Therapeutics In | 0.3 | $4.8M | 829k | 5.83 | |
Dynavax Technologies (DVAX) | 0.3 | $4.7M | 249k | 18.70 | |
Johnson Controls International Plc equity (JCI) | 0.3 | $4.3M | 285k | 15.00 | |
Meridian Ban | 0.3 | $4.1M | 199k | 20.60 | |
Affimed Therapeutics B V | 0.3 | $4.2M | 3.2M | 1.30 | |
Forescout Technologies | 0.3 | $4.0M | 125k | 31.89 | |
Esterline Technologies Corporation | 0.2 | $3.3M | 44k | 74.71 | |
Foundation Medicine | 0.2 | $3.1M | 45k | 68.20 | |
Cellectis S A (CLLS) | 0.2 | $2.8M | 98k | 29.15 | |
Sangamo Biosciences (SGMO) | 0.1 | $2.1M | 128k | 16.40 | |
Facebook Inc cl a (META) | 0.1 | $1.9M | 3.3k | 572.43 | |
Mitsubishi UFJ Financial (MUFG) | 0.1 | $1.6M | 98k | 16.61 | |
PowerShares QQQ Trust, Series 1 | 0.1 | $1.7M | 5.8k | 287.20 | |
Rigel Pharmaceuticals | 0.1 | $1.2M | 311k | 3.88 | |
Scpharmaceuticals (SCPH) | 0.1 | $1.3M | 107k | 12.09 | |
Ardagh Group S A cl a | 0.1 | $1.1M | 54k | 21.09 | |
Puma Biotechnology (PBYI) | 0.1 | $987k | 4.7k | 210.00 | |
Five Prime Therapeutics | 0.1 | $839k | 38k | 21.92 | |
SPDR S&P Retail (XRT) | 0.1 | $756k | 8.0k | 94.50 | |
Bioverativ Inc Com equity | 0.0 | $588k | 5.0k | 117.67 | |
Bristol Myers Squibb (BMY) | 0.0 | $410k | 7.0k | 58.57 | |
Gilead Sciences (GILD) | 0.0 | $428k | 2.1k | 208.78 | |
Curis | 0.0 | $444k | 634k | 0.70 | |
Clovis Oncology | 0.0 | $375k | 3.0k | 125.00 | |
Biogen Idec (BIIB) | 0.0 | $210k | 1.8k | 120.00 | |
Aon | 0.0 | $208k | 1.0k | 208.00 | |
General Electric Company | 0.0 | $5.0k | 10k | 0.50 |